line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,KREBSBIO.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,KREBSBIO.NS
Normalized EBITDA,2025-03-31 00:00:00,-143206000.0,KREBSBIO.NS
Total Unusual Items,2025-03-31 00:00:00,0.0,KREBSBIO.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Reconciled Depreciation,2025-03-31 00:00:00,66892000.0,KREBSBIO.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,55557000.0,KREBSBIO.NS
EBITDA,2025-03-31 00:00:00,-143206000.0,KREBSBIO.NS
EBIT,2025-03-31 00:00:00,-210098000.0,KREBSBIO.NS
Net Interest Income,2025-03-31 00:00:00,-59142000.0,KREBSBIO.NS
Interest Expense,2025-03-31 00:00:00,59142000.0,KREBSBIO.NS
Interest Income,2025-03-31 00:00:00,,KREBSBIO.NS
Normalized Income,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Total Expenses,2025-03-31 00:00:00,650308000.0,KREBSBIO.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,KREBSBIO.NS
Diluted Average Shares,2025-03-31 00:00:00,,KREBSBIO.NS
Basic Average Shares,2025-03-31 00:00:00,,KREBSBIO.NS
Diluted EPS,2025-03-31 00:00:00,,KREBSBIO.NS
Basic EPS,2025-03-31 00:00:00,,KREBSBIO.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Net Income Common Stockholders,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,,KREBSBIO.NS
Net Income Continuous Operations,2025-03-31 00:00:00,-269393000.0,KREBSBIO.NS
Tax Provision,2025-03-31 00:00:00,153000.0,KREBSBIO.NS
Pretax Income,2025-03-31 00:00:00,-269240000.0,KREBSBIO.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,7089000.0,KREBSBIO.NS
Special Income Charges,2025-03-31 00:00:00,0.0,KREBSBIO.NS
Other Special Charges,2025-03-31 00:00:00,,KREBSBIO.NS
Write Off,2025-03-31 00:00:00,,KREBSBIO.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-59142000.0,KREBSBIO.NS
Total Other Finance Cost,2025-03-31 00:00:00,,KREBSBIO.NS
Interest Expense Non Operating,2025-03-31 00:00:00,59142000.0,KREBSBIO.NS
Interest Income Non Operating,2025-03-31 00:00:00,,KREBSBIO.NS
Operating Income,2025-03-31 00:00:00,-217189000.0,KREBSBIO.NS
Operating Expense,2025-03-31 00:00:00,594751000.0,KREBSBIO.NS
Other Operating Expenses,2025-03-31 00:00:00,361875000.0,KREBSBIO.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,66892000.0,KREBSBIO.NS
Amortization,2025-03-31 00:00:00,,KREBSBIO.NS
Depreciation Income Statement,2025-03-31 00:00:00,66892000.0,KREBSBIO.NS
Selling General And Administration,2025-03-31 00:00:00,,KREBSBIO.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,KREBSBIO.NS
General And Administrative Expense,2025-03-31 00:00:00,,KREBSBIO.NS
Rent And Landing Fees,2025-03-31 00:00:00,,KREBSBIO.NS
Gross Profit,2025-03-31 00:00:00,377562000.0,KREBSBIO.NS
Cost Of Revenue,2025-03-31 00:00:00,55557000.0,KREBSBIO.NS
Total Revenue,2025-03-31 00:00:00,433119000.0,KREBSBIO.NS
Operating Revenue,2025-03-31 00:00:00,433119000.0,KREBSBIO.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,KREBSBIO.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.0,KREBSBIO.NS
Normalized EBITDA,2024-03-31 00:00:00,-82727000.0,KREBSBIO.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,KREBSBIO.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Reconciled Depreciation,2024-03-31 00:00:00,67663000.0,KREBSBIO.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,65873000.0,KREBSBIO.NS
EBITDA,2024-03-31 00:00:00,-82727000.0,KREBSBIO.NS
EBIT,2024-03-31 00:00:00,-150390000.0,KREBSBIO.NS
Net Interest Income,2024-03-31 00:00:00,-46894000.0,KREBSBIO.NS
Interest Expense,2024-03-31 00:00:00,46894000.0,KREBSBIO.NS
Interest Income,2024-03-31 00:00:00,1567000.0,KREBSBIO.NS
Normalized Income,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Total Expenses,2024-03-31 00:00:00,659118000.0,KREBSBIO.NS
Rent Expense Supplemental,2024-03-31 00:00:00,5788000.0,KREBSBIO.NS
Diluted Average Shares,2024-03-31 00:00:00,21561093.0,KREBSBIO.NS
Basic Average Shares,2024-03-31 00:00:00,21561093.0,KREBSBIO.NS
Diluted EPS,2024-03-31 00:00:00,-9.15,KREBSBIO.NS
Basic EPS,2024-03-31 00:00:00,-9.15,KREBSBIO.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Net Income Common Stockholders,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,,KREBSBIO.NS
Net Income Continuous Operations,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Tax Provision,2024-03-31 00:00:00,0.0,KREBSBIO.NS
Pretax Income,2024-03-31 00:00:00,-197284000.0,KREBSBIO.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,4513000.0,KREBSBIO.NS
Special Income Charges,2024-03-31 00:00:00,0.0,KREBSBIO.NS
Other Special Charges,2024-03-31 00:00:00,,KREBSBIO.NS
Write Off,2024-03-31 00:00:00,,KREBSBIO.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-46894000.0,KREBSBIO.NS
Total Other Finance Cost,2024-03-31 00:00:00,35000.0,KREBSBIO.NS
Interest Expense Non Operating,2024-03-31 00:00:00,46894000.0,KREBSBIO.NS
Interest Income Non Operating,2024-03-31 00:00:00,1567000.0,KREBSBIO.NS
Operating Income,2024-03-31 00:00:00,-154903000.0,KREBSBIO.NS
Operating Expense,2024-03-31 00:00:00,593245000.0,KREBSBIO.NS
Other Operating Expenses,2024-03-31 00:00:00,360841000.0,KREBSBIO.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,67663000.0,KREBSBIO.NS
Amortization,2024-03-31 00:00:00,1838000.0,KREBSBIO.NS
Depreciation Income Statement,2024-03-31 00:00:00,67663000.0,KREBSBIO.NS
Selling General And Administration,2024-03-31 00:00:00,6001000.0,KREBSBIO.NS
Selling And Marketing Expense,2024-03-31 00:00:00,,KREBSBIO.NS
General And Administrative Expense,2024-03-31 00:00:00,6001000.0,KREBSBIO.NS
Rent And Landing Fees,2024-03-31 00:00:00,5788000.0,KREBSBIO.NS
Gross Profit,2024-03-31 00:00:00,438342000.0,KREBSBIO.NS
Cost Of Revenue,2024-03-31 00:00:00,65873000.0,KREBSBIO.NS
Total Revenue,2024-03-31 00:00:00,504215000.0,KREBSBIO.NS
Operating Revenue,2024-03-31 00:00:00,504215000.0,KREBSBIO.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,KREBSBIO.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.0,KREBSBIO.NS
Normalized EBITDA,2023-03-31 00:00:00,-151624000.0,KREBSBIO.NS
Total Unusual Items,2023-03-31 00:00:00,0.0,KREBSBIO.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Reconciled Depreciation,2023-03-31 00:00:00,65585000.0,KREBSBIO.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,423518000.0,KREBSBIO.NS
EBITDA,2023-03-31 00:00:00,-151624000.0,KREBSBIO.NS
EBIT,2023-03-31 00:00:00,-217209000.0,KREBSBIO.NS
Net Interest Income,2023-03-31 00:00:00,-27529000.0,KREBSBIO.NS
Interest Expense,2023-03-31 00:00:00,29710000.0,KREBSBIO.NS
Interest Income,2023-03-31 00:00:00,2203000.0,KREBSBIO.NS
Normalized Income,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Total Expenses,2023-03-31 00:00:00,740735000.0,KREBSBIO.NS
Rent Expense Supplemental,2023-03-31 00:00:00,6879000.0,KREBSBIO.NS
Diluted Average Shares,2023-03-31 00:00:00,21560586.0,KREBSBIO.NS
Basic Average Shares,2023-03-31 00:00:00,21560586.0,KREBSBIO.NS
Diluted EPS,2023-03-31 00:00:00,-11.3,KREBSBIO.NS
Basic EPS,2023-03-31 00:00:00,-11.3,KREBSBIO.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Net Income Common Stockholders,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,,KREBSBIO.NS
Net Income Continuous Operations,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Tax Provision,2023-03-31 00:00:00,0.0,KREBSBIO.NS
Pretax Income,2023-03-31 00:00:00,-246919000.0,KREBSBIO.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,6201000.0,KREBSBIO.NS
Special Income Charges,2023-03-31 00:00:00,0.0,KREBSBIO.NS
Other Special Charges,2023-03-31 00:00:00,,KREBSBIO.NS
Write Off,2023-03-31 00:00:00,,KREBSBIO.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-27529000.0,KREBSBIO.NS
Total Other Finance Cost,2023-03-31 00:00:00,22000.0,KREBSBIO.NS
Interest Expense Non Operating,2023-03-31 00:00:00,29710000.0,KREBSBIO.NS
Interest Income Non Operating,2023-03-31 00:00:00,2203000.0,KREBSBIO.NS
Operating Income,2023-03-31 00:00:00,-219391000.0,KREBSBIO.NS
Operating Expense,2023-03-31 00:00:00,317217000.0,KREBSBIO.NS
Other Operating Expenses,2023-03-31 00:00:00,48810000.0,KREBSBIO.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,65585000.0,KREBSBIO.NS
Amortization,2023-03-31 00:00:00,1839000.0,KREBSBIO.NS
Depreciation Income Statement,2023-03-31 00:00:00,63746000.0,KREBSBIO.NS
Selling General And Administration,2023-03-31 00:00:00,8598000.0,KREBSBIO.NS
Selling And Marketing Expense,2023-03-31 00:00:00,,KREBSBIO.NS
General And Administrative Expense,2023-03-31 00:00:00,8598000.0,KREBSBIO.NS
Rent And Landing Fees,2023-03-31 00:00:00,6879000.0,KREBSBIO.NS
Gross Profit,2023-03-31 00:00:00,97826000.0,KREBSBIO.NS
Cost Of Revenue,2023-03-31 00:00:00,423518000.0,KREBSBIO.NS
Total Revenue,2023-03-31 00:00:00,521344000.0,KREBSBIO.NS
Operating Revenue,2023-03-31 00:00:00,521344000.0,KREBSBIO.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Normalized EBITDA,2022-03-31 00:00:00,-328456000.0,KREBSBIO.NS
Total Unusual Items,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Reconciled Depreciation,2022-03-31 00:00:00,62966000.0,KREBSBIO.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,654674000.0,KREBSBIO.NS
EBITDA,2022-03-31 00:00:00,-328456000.0,KREBSBIO.NS
EBIT,2022-03-31 00:00:00,-391422000.0,KREBSBIO.NS
Net Interest Income,2022-03-31 00:00:00,-50332000.0,KREBSBIO.NS
Interest Expense,2022-03-31 00:00:00,53846000.0,KREBSBIO.NS
Interest Income,2022-03-31 00:00:00,3578000.0,KREBSBIO.NS
Normalized Income,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Total Expenses,2022-03-31 00:00:00,991966000.0,KREBSBIO.NS
Rent Expense Supplemental,2022-03-31 00:00:00,6807000.0,KREBSBIO.NS
Diluted Average Shares,2022-03-31 00:00:00,21560586.0,KREBSBIO.NS
Basic Average Shares,2022-03-31 00:00:00,21560586.0,KREBSBIO.NS
Diluted EPS,2022-03-31 00:00:00,-20.81,KREBSBIO.NS
Basic EPS,2022-03-31 00:00:00,-20.81,KREBSBIO.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Net Income Common Stockholders,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income Continuous Operations,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Tax Provision,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Pretax Income,2022-03-31 00:00:00,-445268000.0,KREBSBIO.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,10169000.0,KREBSBIO.NS
Special Income Charges,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Other Special Charges,2022-03-31 00:00:00,1791000.0,KREBSBIO.NS
Write Off,2022-03-31 00:00:00,0.0,KREBSBIO.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-50332000.0,KREBSBIO.NS
Total Other Finance Cost,2022-03-31 00:00:00,64000.0,KREBSBIO.NS
Interest Expense Non Operating,2022-03-31 00:00:00,53846000.0,KREBSBIO.NS
Interest Income Non Operating,2022-03-31 00:00:00,3578000.0,KREBSBIO.NS
Operating Income,2022-03-31 00:00:00,-394935000.0,KREBSBIO.NS
Operating Expense,2022-03-31 00:00:00,337292000.0,KREBSBIO.NS
Other Operating Expenses,2022-03-31 00:00:00,74703000.0,KREBSBIO.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,62966000.0,KREBSBIO.NS
Amortization,2022-03-31 00:00:00,6386000.0,KREBSBIO.NS
Depreciation Income Statement,2022-03-31 00:00:00,56580000.0,KREBSBIO.NS
Selling General And Administration,2022-03-31 00:00:00,11384000.0,KREBSBIO.NS
Selling And Marketing Expense,2022-03-31 00:00:00,38000.0,KREBSBIO.NS
General And Administrative Expense,2022-03-31 00:00:00,11384000.0,KREBSBIO.NS
Rent And Landing Fees,2022-03-31 00:00:00,6807000.0,KREBSBIO.NS
Gross Profit,2022-03-31 00:00:00,-57643000.0,KREBSBIO.NS
Cost Of Revenue,2022-03-31 00:00:00,654674000.0,KREBSBIO.NS
Total Revenue,2022-03-31 00:00:00,597031000.0,KREBSBIO.NS
Operating Revenue,2022-03-31 00:00:00,597031000.0,KREBSBIO.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,KREBSBIO.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,KREBSBIO.NS
Normalized EBITDA,2021-03-31 00:00:00,,KREBSBIO.NS
Total Unusual Items,2021-03-31 00:00:00,,KREBSBIO.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,KREBSBIO.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,KREBSBIO.NS
Reconciled Depreciation,2021-03-31 00:00:00,,KREBSBIO.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,KREBSBIO.NS
EBITDA,2021-03-31 00:00:00,,KREBSBIO.NS
EBIT,2021-03-31 00:00:00,,KREBSBIO.NS
Net Interest Income,2021-03-31 00:00:00,,KREBSBIO.NS
Interest Expense,2021-03-31 00:00:00,,KREBSBIO.NS
Interest Income,2021-03-31 00:00:00,721000.0,KREBSBIO.NS
Normalized Income,2021-03-31 00:00:00,,KREBSBIO.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,KREBSBIO.NS
Total Expenses,2021-03-31 00:00:00,,KREBSBIO.NS
Rent Expense Supplemental,2021-03-31 00:00:00,9425000.0,KREBSBIO.NS
Diluted Average Shares,2021-03-31 00:00:00,19620586.0,KREBSBIO.NS
Basic Average Shares,2021-03-31 00:00:00,19620586.0,KREBSBIO.NS
Diluted EPS,2021-03-31 00:00:00,-14.453493,KREBSBIO.NS
Basic EPS,2021-03-31 00:00:00,-14.453493,KREBSBIO.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,KREBSBIO.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,KREBSBIO.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,KREBSBIO.NS
Net Income,2021-03-31 00:00:00,,KREBSBIO.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,KREBSBIO.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,0.0,KREBSBIO.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,KREBSBIO.NS
Tax Provision,2021-03-31 00:00:00,,KREBSBIO.NS
Pretax Income,2021-03-31 00:00:00,,KREBSBIO.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,KREBSBIO.NS
Special Income Charges,2021-03-31 00:00:00,,KREBSBIO.NS
Other Special Charges,2021-03-31 00:00:00,465000.0,KREBSBIO.NS
Write Off,2021-03-31 00:00:00,802000.0,KREBSBIO.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,KREBSBIO.NS
Total Other Finance Cost,2021-03-31 00:00:00,73000.0,KREBSBIO.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,KREBSBIO.NS
Interest Income Non Operating,2021-03-31 00:00:00,721000.0,KREBSBIO.NS
Operating Income,2021-03-31 00:00:00,,KREBSBIO.NS
Operating Expense,2021-03-31 00:00:00,,KREBSBIO.NS
Other Operating Expenses,2021-03-31 00:00:00,,KREBSBIO.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,KREBSBIO.NS
Amortization,2021-03-31 00:00:00,2602000.0,KREBSBIO.NS
Depreciation Income Statement,2021-03-31 00:00:00,,KREBSBIO.NS
Selling General And Administration,2021-03-31 00:00:00,6762000.0,KREBSBIO.NS
Selling And Marketing Expense,2021-03-31 00:00:00,47000.0,KREBSBIO.NS
General And Administrative Expense,2021-03-31 00:00:00,6715000.0,KREBSBIO.NS
Rent And Landing Fees,2021-03-31 00:00:00,3065000.0,KREBSBIO.NS
Gross Profit,2021-03-31 00:00:00,,KREBSBIO.NS
Cost Of Revenue,2021-03-31 00:00:00,,KREBSBIO.NS
Total Revenue,2021-03-31 00:00:00,,KREBSBIO.NS
Operating Revenue,2021-03-31 00:00:00,,KREBSBIO.NS
